Weight Loss

Captide Labs offers research peptides for weight loss and metabolic studies in precision-dosed capsule format. The compounds in this category — Orforglipron, BAM-15, 5-Amino-1MQ, and Tesofensine — represent some of the most actively researched mechanisms in contemporary weight loss research, spanning oral GLP-1 receptor agonism, mitochondrial uncoupling, NNMT inhibition, and triple monoamine reuptake inhibition.

Each weight loss research peptide in our catalog is supplied as a precision-filled oral capsule with verified identity and dose, eliminating the variability of manual reconstitution. Every batch is independently verified by Ethos Laboratories — an ISO 17025–accredited third-party facility — with the full Certificate of Analysis published on each product page.

If you’re investigating oral peptide pathways for weight management research, the capsule format makes consistent dosing protocols significantly easier to maintain than traditional vial-and-syringe formats. All Captide Labs weight loss research peptides are sold strictly for research and laboratory use only — not for human or animal consumption.